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704Objective: Inflammation is associated with the formation of aortic aneurysm. This study investigates the role of
inducible Cys-X-Cys chemokine receptor 3 and its ligands in the pathogenesis of arterial aneurysms.
Methods: Plasma samples from patients with or without a diagnosis of thoracic aortic aneurysms were analyzed
by enzyme-linked immunosorbent assay for the T-helper 1 cytokine interferon-g and the interferon-g–inducible
chemokine receptor 3 ligands: interferon-inducible protein-10, interferon-inducible T-cell alpha chemoattrac-
tant, and monokine induced by interferon gamma. Patient charts were reviewed for demographics, initial aortic
diameter, and growth rates. Aneurysm diameter and growth rates were correlated with plasma cytokine and che-
mokine levels using linear regression analysis. We used an animal model of aneurysm formation, where calcium
chloride is applied topically to the carotid arteries of wild-type and Cys-X-Cys chemokine receptor 3/mice.
After 10 weeks, the arteries were harvested and analyzed by histology and immunohistochemistry.
Results: Patients with thoracic aortic aneurysms had significant elevations in circulating interferon-g,
interferon-inducible protein-10, interferon-inducible T-cell alpha chemoattractant, and monokine induced by in-
terferon gamma compared with referent patients (P<.001). Cytokine and chemokine plasma levels did not cor-
relate with aneurysm size or growth rates. Cys-X-Cys chemokine receptor 3/ mice were protected from
aneurysm formation and showed decreased vascular infiltration by CD45þ leukocytes.
Conclusions: Elevated plasma levels of interferon-g and Cys-X-Cys chemokine receptor 3-binding chemokines
are present in patients with thoracic aortic aneurysms. The Cys-X-Cys chemokine receptor 3 receptor is neces-
sary for vascular inflammation and the formation of arterial aneurysms in mice. (J Thorac Cardiovasc Surg
2012;143:704-10)Aortic aneurysms may cause severe complications or death
as a consequence of progressive enlargement, dissection,
and rupture of the vessel wall.1 Analyses of clinical speci-
mens and experimental models have led to an increased un-
derstanding of the role of inflammation in the pathogenesis
of aneurysmal disease where medial degeneration and
vascular cell death in aneurysmal aortas are associated
with leukocytic infiltrates.2-4 The recruitment of
leukocytes into the aortic media is promoted by
chemokines and elastin degradation peptides, whereas
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The Journal of Thoracic and Cardiovascular Surgwall produce proinflammatory factors that contribute to
aortic wall injury and expansion.5-8 Activated T cells
differentiate from na€ıve precursors into different effector
populations characterized by the production of particular
cytokines, including that of T-helper (Th)1 cells that
secrete their signature cytokine, interferon (IFN)-g.
Chemokines, such as interferon-inducible protein-10
(IP-10), interferon-inducible T-cell alpha chemoattractant
(I-TAC), and monokine induced by interferon gamma
(Mig), are induced by IFN-g and bind to and activate the
Cys-X-Cys chemokine receptor 3 (CXCR3), preferentially
expressed by Th1 cells (Figure 1). We previously reported
that Th1-type immune responses are associated with human
thoracic aortic aneurysms; specifically, transmural aortic in-
flammation correlates with increased aneurysm diameter
and is characterized by activated T cells; increased expres-
sion of IFN-g, IP-10, andMig; and the selective recruitment
of CXCR3-expressing Th1 cells.9 The importance of Th1
immune responses in the development of abdominal aortic
aneurysms has been demonstrated in IFN-g/mice using
a model of topical calcium chloride application and in pa-
tients with abdominal aortic aneurysm in whom serum
levels of INF-g are elevated.10,11 These clinical and
experimental data indicate that Th1-type immune responsesery c March 2012
Abbreviations and Acronyms
CXCR3 ¼ Cys-X-Cys chemokine receptor 3
IFN ¼ interferon
IL ¼ interleukin
IP-10 ¼ interferon-inducible protein-10
I-TAC ¼ interferon-inducible T-cell alpha
chemoattractant
Mig ¼ monokine induced by interferon
gamma
Th ¼ T-helper
WT ¼ wild type
Gallo et al Evolving Technology/Basic Scienceare important in the pathogenesis of aortic aneurysms and
argue against the hypothesis that arterial enlargement re-
sults from Th2-dominant immune responses.12
An improved understanding of the role of cytokines and
chemokines in aneurysm pathophysiology may lead to
novel therapies. To determine the role of CXCR3 chemo-
kines in aneurysmal disease, we measured their plasma
levels in patients with thoracic aortic aneurysms and ex-
amined the formation of arterial aneurysm in CXCR3/
mice.E
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Patients
Patients with thoracic aortic aneurysms and referent controls were en-
rolled at VA Connecticut Healthcare Systems between January 2005 and
April 2006. The sizes of the thoracic aortic aneurysms were measured by
computed tomography. Histories were obtained from chart reviews, and
interviews were performed by an investigator who was blinded to the re-
sults of plasma evaluations. Subjects who had a history of chronic infec-
tion, were immunocompromised, or were taking oral corticosteroids were
excluded from the study. Referent patients of similar age and gender to the
experimental group, but without a known diagnosis of aortic aneurysms,
were randomly enrolled at the West Haven VA primary care clinic. The
referent patients did not undergo imaging studies to definitively excluded
aortic aneurysm. Peripheral blood samples were collected in EDTA tubes,
the plasma was separated by centrifugation, and the specimens were
stored at 80C until analyzed. Informed consent was obtained on all
study participants. The research was approved by the institutional review
boards.
Enzyme-Linked Immunosorbent Assay
Measurements of IFN-g, IP-10, I-TAC, and Mig were performed using
enzyme-linked immunosorbent assay kits according to the manufacturer’s
directions (R&D Systems, Minneapolis, Minn). The lower limit of detec-
tion (ie, the lowest concentration of cytokine standard used to construct
a reference line) was 15.6 pg/mL for IFN-g and Mig, 7.8 pg/mL for
IP-10, and 1.9 pg/mL for I-TAC.
Mice
CXCR3/mice were obtained from Paul Noble, MD (Yale University),
and used at 8 to 12 weeks of age. These animals have been described in de-
tail13 and were crossed onto a C57BL/6J background for more than 5 gen-
erations. Age- and sex-matched wild-type (WT) C57BL/6J mice wereThe Journal of Thoracic and Capurchased from The Jackson Laboratory (Bar Harbor, Me). Animal exper-
iments were approved by the Institutional Animal Care and Use Committee
at Yale University.
Model of Aneurysm Formation
Aneurysms were induced in the carotid artery by topical application of
calcium chloride, as previously described.14 Briefly, mice were anesthe-
tized and the right carotid artery was accessed through a midline anterior
neck incision. Calcium chloride (0.5mol/L) was applied to the entire length
of the right carotid artery for 15 minutes, and the vessel was irrigated with
0.9% sterile saline. The left carotid was exposed, and 0.9% sterile saline
was similarly applied. The incision was closed. At 10 weeks postopera-
tively, the mice were killed by cardiac perfusion with saline followed by
4% paraformaldehyde. The right and left carotid arteries were harvested
en bloc as a single specimen attached to the aorta, fixed in 10% formalin
for 3 hours, and fixed in 15% glucose overnight. The carotid arteries
were placed in parallel in Tissue-Tek O.C.T. Compound (Miles Inc,
Elkhart, Ind).
Morphometry
Transverse sections of the carotid arteries more than 5 mm in length
were stained with hematoxylin–eosin. From these sections, the internal
and external elastic lamina perimeters were measured using Image 1.62c
software (Scion, Frederick,Md). Vessel area was calculated from perimeter
measurements assuming that the vessels were circular in shape. The medial
thickness was determined by measuring 4 separate areas of each vessel and
averaging these measurements.
Immunohistochemistry
Formalin-fixed and Tissue-Tek O.C.T.-embedded carotid artery speci-
mens were sectioned at a thickness of 8 mm. The sections were incubated
with monoclonal antibodies to mouse: CD45, F4/80, CD3 (Abcam Inc,
Cambridge, Mass), immunoglobulin-G, and a-actin (Sigma-Aldrich, St
Louis, Mo). Binding of secondary antibodies (Jackson ImmunoResearch,
West Grove, Pa) was detected with peroxidase/3-amino ethyl carbazole
kits (Vector Laboratories, Burlingame, Calif).
Statistical Analysis
Statistical analyses were performed using Prism version 4 (GraphPad
Software, San Diego, Calif) statistical software. Subject characteristics
were compared using chi-square or Fisher exact test for proportions.
Mean comparisons between 2 groups and multiple groups were performed
with a Student t test and 1-way analysis of variance, respectively. Correla-
tion coefficients were calculated using Pearson correlation.
RESULTS
Patient Characteristics
Twenty-six patients with thoracic aortic aneurysms and
54 reference patients were enrolled. The 2 groups were of
similar age, gender, and race, and had similar risk factors
and diagnosis of atherosclerosis (Table 1).
The average aneurysm size was 5.03 cm, with the major-
ity of aneurysms located in the ascending thoracic aorta
(81%). Open surgical replacement was performed in 38%
of patients with aneurysm, whereas the remaining patients
were not surgical candidates because of aneurysm size or
medical comorbidities, or they refused surgical interven-
tion. Patients who did not have operative repair were fol-
lowed with serial radiologic imaging. Growth rates were
calculated for patients with multiple imaging modalitiesrdiovascular Surgery c Volume 143, Number 3 705
FIGURE 1. Schema of Th1 immune responses and the IFN-g cytokine axis in arterial immune responses. Activation of na€ıve T-cell precursors, or Th0
cells, occurs in draining lymph nodes of the aorta or periadventitial tertiary lymphoid organs that organize around chronically inflamed arteries. The cytokine
milieu at the time of cognate recognition of antigen skews the development of CD4þeffector T cells into different lineages characterized by the polarization
of secreted cytokines, that is, IFN-g–producing Th1 cells, IL-4–producing Th2 cells, IL-10–producing Th3 cells, and IL-17–producing Th17 cells. Recir-
culating T cells reach the vessel wall via the luminal endothelium or from microvessels of the adventitia and occasionally outer media of the thoracic aorta.
Th1 cells preferentially express the chemokine receptor CXCR3, and their recruitment, retention, and activation are augmented by the IFN-g–inducible
CXCR3 ligands IP-10, Mig, and I-TAC that are robustly produced by vascular cells, such as medial smooth muscle cells. The positive feedback loop of
IFN-g–inducing factors, IFN-g, and IFN-g–inducible chemokines is referred to as the IFN-g cytokine axis. IP-10, Interferon-inducible protein-10;
I-TAC, interferon-inducible T-cell alpha chemoattractant; Mig, monokine induced by interferon gamma; SMC, smooth muscle cell; IFN, interferon;
Th, T-helper; CXCR3, Cys-X-Cys chemokine receptor 3.
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with a mean of 0.69  1.4 cm/year.
Elevated Circulating Interferon-g and Interferon-g–
Inducible Cys-X-Cys Chemokine Receptor 3 Ligands
in Patients With Aneurysms
To determine whether circulating markers of adaptive
immunity were present in patients with thoracic aortic aneu-
rysms, we measured plasma levels of IFN-g and the IFN-g–
inducible CXCR3 ligands IP-10, I-TAC, and Mig. Patients
with thoracic aortic aneurysms had elevated plasma levels
of IFN-g, IP-10, I-TAC, and Mig compared with reference
patients (Figure 2). No patients with aneurysms had unde-
tectable I-TAC plasma levels (<1.9 pg/mL), whereas 47%
of control patients had undetectable I-TAC levels. All pa-
tients with aneurysms had elevated plasma levels of at least
1 of the 4 circulating proinflammatory factors, and 96% of
patients with aneurysm had elevated plasma values of 2 of
the 4 cytokine/chemokines. Therewas no significant correla-
tion between plasma levels of IFN-g or any of the CXCR3
ligands with aneurysm diameter or growth rate (Figure 3).
These results demonstrate that circulating chemokines are in-
creased in patients with ascending aortic aneurysm, but the706 The Journal of Thoracic and Cardiovascular Surgdegree of elevation does not correlate with either aneurysm
size or its rate of growth, perhaps the more appropriate func-
tion to assess for vascular responses to inflammatory stimuli.
Cys-X-Cys Chemokine Receptor 3 Is Required for
Arterial Aneurysm Formation in Mice
We used a well-described mouse model of aneurysm for-
mation to determine whether CXCR3 ligands play a role in
the early pathogenesis of aneurysmal disease.14 By using
topical application of calcium chloride, we evaluated aneu-
rysm formation and growth in WT versus CXCR3/mice
over a 10-week period (Figure 4, A). WT mice showed sig-
nificant aneurysm formation in treated common carotid ar-
teries, and the vessel area increased by 47%. However,
CXCR3/mice did not demonstrate any aneurysm forma-
tion in response to calcium chloride treatment (Figure 4,
B). CXCR3/ mice had slightly larger carotid arteries at
baseline compared with WT mice; however, this was not
statistically significant. There was no difference in the
thickness of the media in any of the groups.
To determine whether inhibition of aneurysm formation
in CXCR3/mice was associated with reduced inflamma-
tion, we examined the carotid arteries of WT andery c March 2012
TABLE 1. Clinical characteristics of human subjects with and without thoracic aortic aneurysms
Controls (n ¼ 54) Aneurysms (n ¼ 26) P value
Age (y) 68.4  10.5 68.8  12.4 .89
Gender (male/female) 50 (93%)/4 (7%) 23 (88%)/3 (12%) .67
Race (white/other) 21 (81%)/5 (19%) 49 (91%)/5 (9%) .28
Risk factors for atherosclerosis
Diabetes 12 (22%) 5 (19%) .76
Hyperlipidemia 14 (26%) 4 (15%) .29
Hypertension 30 (56%) 17 (65%) .47
Current smoker 5 (9%) 4 (15%) .42
Diagnosis of atherosclerosis* 4 (7%) 4 (15%) .27
Data are means  SD or N (% of total). P values for comparison between controls and aneurysm subjects calculated by Fisher exact test or chi-square for proportions and non-
paired t test for means. *Includes coronary artery disease, cerebrovascular disease, and peripheral vascular disease.
Gallo et al Evolving Technology/Basic ScienceCXCR3/ mice for the presence of inflammatory cells.
There was an increased number of infiltrating cells that ex-
pressed the pan-leukocyte marker CD45þ in the arteries of
WT animals treated with calcium chloride versus sodium
chloride; however, there was no significant increase of
CD45þ cells in treated arteries of CXCR3/ mice
(Figure 4, C). The inflammatory cells were localized to
the adventitia, without any infiltration of the media, and
consisted of both F4/80þ macrophages and CD3þ T cells
(data not shown). This demonstrates that CXCR3 is re-
quired for recruitment or retention of CD45þ leukocytes,
initiation of inflammatory response within the vessel wall,
and subsequent formation of arterial aneurysm.
DISCUSSION
We demonstrate that patients with thoracic aortic aneu-
rysms have elevated plasma levels of circulating IFN-gFIGURE 2. Circulating chemokines in serum of humans with and without aorti
picograms/milliliter as measured by enzyme-linked immunosorbent assay. Value
interferon-inducible T-cell alpha chemoattractant; IP-10, interferon-inducible p
The Journal of Thoracic and Caand the IFN-g–inducible chemokines, IP-10, I-TAC, and
Mig, compared with referent subjects. To extend these de-
scriptive observations, we find that CXCR3, the cognate re-
ceptor for IP-10, I-TAC, and Mig, is necessary for calcium
chloride–induced aneurysm formation in mice. These re-
sults suggest that Th1-type immune responses and their ef-
fector chemokines are essential in the pathogenesis of the
disease.
A role for inflammation in aneurysm progression and
rupture has been established.15 In particular, the Th1 im-
mune response has been identified by a number of groups
as a critical determinant of pathogenesis of human aortic an-
eurysms.9,16 However, downstream effectors of the Th1
response that are involved in aneurysm pathogenesis have
not been reported. We previously reported that IFN-g and
IFN-g–inducible CXCR3 ligands co-localize in the walls
of thoracic aortic aneurysms.9We extend these observationsc aneurysms. IFN-g (A), IP-10 (B), I-TAC (C), andMig (D) plasma levels in
s are mean standard error of the mean. *P<.001. IFN, Interferon; I-TAC,
rotein-10; Mig, monokine induced by interferon gamma.
rdiovascular Surgery c Volume 143, Number 3 707
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FIGURE 3. Circulating chemokines in patients with aortic aneurysms do not correlate with aneurysm diameter or growth rate. Scatter plots of IFN-g
(A, B), IP-10 (B, C), I-TAC (D, E), and Mig (F, G) plasma levels with aneurysm diameter (left) or growth rates (right). Growth rates were determined
for patients with serial images (73%, n ¼ 19). Cytokine and chemokine levels are expressed in picograms/milliliter as measured by enzyme-linked immu-
nosorbent assay. r is the correlation coefficient calculated using Pearson correlation. IFN, Interferon; I-TAC, interferon-inducible T-cell alpha chemoattrac-
tant; IP-10, interferon-inducible protein-10; Mig, monokine induced by interferon gamma.
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IP-10, I-TAC, andMig in patients with thoracic aortic aneu-
rysms. It has been reported that cytokines, such as interleu-
kin (IL)-1b, IL-6, and tumor necrosis factor-a, are elevated
in the serum of patients with abdominal aortic aneurysms
compared with patients with coronary artery disease and
vascular disease-free controls.10,17 IFN-g was also found708 The Journal of Thoracic and Cardiovascular Surgto be elevated in the serum of women with abdominal
aortic aneurysm.10 We were unable to detect a correlation
between plasma levels of IFN-g–inducible chemokines
with aneurysm diameter or growth rate, 2 potential surro-
gate measurements of disease severity. Lack of correlation
could simply reflect variation in human subjects in a rela-
tively small study population; in fact, there is noery c March 2012
FIGURE 4. CXCR3/mice do not develop aneurysms. A, Gross photographs of aneurysm development in calcium chloride–treated right common carotid
arteries versus saline-treated left common carotid arteries in WT mice at days 0, 28, and 70 (right to left); bars represent artery diameter. B, Bar graphs
showing the average internal elastic lamina perimeters, external elastic lamina perimeters, and vessel area of the calcium chloride–treated (black bars)
and saline-treated (white bars) carotid arteries. WT, n ¼ 8; CXCR3/, n ¼ 8. Values are mean  standard error of the mean. *P<.05. C, Infiltrating
CD45þ leukocytes in calcium chloride–treated versus saline-treated carotid arteries in WT and CXCR3/mice were detected by immunohistochemistry.
Bar graphs represent the mean number of CD45þ cells per artery cross-section. WT, n ¼ 6; CXCR3/, n ¼ 5. Values are mean  standard error of the
mean. *P< .05. RCA, Right coronary artery; LCA, left coronary artery; IEL, internal elastic lamina; EEL, external elastic lamina; WT, wild type;
CXCR3, Cys-X-Cys chemokine receptor 3.
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eurysm diameter or expansion rate.10 In addition, circulat-
ing levels may not reflect tissue levels or activity. On the
other hand, the lack of correlation suggests an advanced dis-
ease state of human aneurysms once clinically diagnosed,
and these chemokines may be responsible for early initia-
tion rather than progression of the disease. Arguably, we
may have increased the power of our study by including pa-
tients with aneurysms at any arterial location. There are sev-
eral similarities between thoracic and aortic aneurysms
regarding leukocytic infiltrates of the vessel wall predicting
similar vascular responses to inflammatory stimuli.2-6
However, distinct differences have been documented in
their pathogenesis, for example, Th1-dominant immune re-
sponses in thoracic aortic aneurysms versus Th2-dominantThe Journal of Thoracic and Caimmune responses in abdominal aortic aneurysms.9,12 We
therefore focused our study on thoracic aortic aneurysms
exclusively to avoid confounding factors and variability
between disease processes. An additional limitation of
this study pertains to the control group. The referent
patients were not known to have aneurysmal disease, but
this was not definitely excluded by imaging studies.
However, in a population-based study, the incidence of tho-
racic aortic aneurysm was 5.9 per 100,000 person-year and
is therefore unlikely to be present in our randomly selected
control group.18
Because elevated circulating CXCR3 ligands in patients
with aneurysmal disease may reflect late-stage disease or
coexistent atherosclerotic disease, we also examined an an-
imal model of aneurysm formation to test our hypothesisrdiovascular Surgery c Volume 143, Number 3 709
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aneurysm pathogenesis. The lack of aneurysm formation in
CXCR3/mice supports that hypothesis and is consistent
with previous reports that the Th1-type responses play
a role in aneurysm formation.9,11 In addition, our finding
of inflammatory and chemokine involvement in aneurysm
formation using the calcium chloride model of aneurysm
formation agrees with findings of the elastase model.19
These results suggest the importance of inflammation and
Th1-type immune responses in the pathogenesis of aneurys-
mal disease and support a role of CXCR3 in aneurysmal dis-
eases. Previous reports using a similar animal model
revealed no attenuation of abdominal aortic aneurysm for-
mation in CXCR3/mice.20 The pathogenesis of thoracic
and abdominal aortic aneurysms might be different or
site-specific, because ascending thoracic aneurysms are as-
sociated with preservation, not loss, of medial smooth mus-
cle cells.21 Different segments of the aorta have different
embryologic origins, where the ascending aorta and arch
are of neural crest origin but the more distal part corre-
sponds to the embryologic dorsal aorta. Our animal model
of aneurysm formation used the carotid arteries, which
may have different results than in the aorta. However, sim-
ilar results have been reported in the aorta and carotid ar-
teries, and carotid arteries are of embryologically similar
derivation as thoracic aorta but not abdominal aorta.22-24
Other studies have documented a role for IFN-g in
calcium chloride–induced aneurysms of the abdominal
aorta.11 Also, deletion of certain chemokine receptors,
such as CCR2, prevented aortic aneurysm formation in
the same murine model.20 One problem with extrapolating
results from knockout murine models to clinical disease is
that genetic deletion strategies affect the development of
the immune system, whereas pathologic conditions are gen-
erally acquired during adult life.
CONCLUSIONS
Th1-type immune responses are essential in the patho-
genesis of aortic aneurysms, and modulation of these im-
mune responses may attenuate aneurysm progression and
complications. Detection of circulating chemokines may
represent a sensitive serologic assay of underlying local ar-
terial inflammation through amplification of T-cell–derived
factors on vascular cell responses.
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